[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Pages 55583-55584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25905]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    This is notice that on July 9, 2009, Cody Laboratories Inc., 601 
Yellowstone Avenue, Cody, Wyoming 82414-9321, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as an importer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Raw Opium (9600)............................  II
Concentrate of Poppy Straw (9670)...........  II
------------------------------------------------------------------------

    The company plans to import narcotic raw materials for 
manufacturing and further distribution to its customers. The company is 
registered with DEA as a manufacturer of several controlled substances 
that are manufactured from raw opium, poppy straw, and concentrate of 
poppy straw.

[[Page 55584]]

    As explained in the Correction to Notice of Application pertaining 
to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for 
hearings on applications to import narcotic raw material are not 
appropriate.
    As noted in a previous notice published in the Federal Register on 
September 23, 1975, (40 FR 43745), all applicants for registration to 
import a basic class of any controlled substances in schedule I or II 
are, and will continue to be, required to demonstrate to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, that the requirements for such registration pursuant to 
21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b),(c),(d),(e), 
and (f) are satisfied.

    Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-25905 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-P